On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulk-substances list, on the basis that the branded drugs are no longer in shortage
A recent study on SCI rats showed that BMSCs probably exert their biological effect through HGF-MET axis activation
BPC-157 or Body Protection Compound-157 is a pentadecapeptide consisting of 15 amino acids
Disclaimer: This blog is for informational purposes only and does not substitute professional medical advice
Formulated by Doctors, Phytochemists & Biotechnologists - OZiva is committed to providing science-backed formulations with pure plant actives to help you achieve desired results without any side effects
Manu Mengi to take a decisive step towards a pain-free, active life